ReviewFrontiers in oncology2026
The future of lung cancer surgery lies between innovations: synergy across the perioperative ERATS pathway.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surgical resection remains the treatment of choice for early-stage lung cancer. Over the past few decades, enhanced recovery after thoracic surgery (ERATS) programs, including preoperative optimization, minimally invasive surgery, opioid-sparing analgesia, early mobilization, patient engagement, and rehabilitation strategies, have been implemented as part of integrated care pathways for lung surgery, aimed at reducing surgical stress and improving functional recovery. Increasing adherence to isolated perioperative care pathway components is associated with a reduction in length of hospital stay, consistent with the 'marginal gains' paradigm, whereby the cumulative implementation of multiple ERAS elements confers greater benefit than any single intervention alone. However, evidence-based studies mainly focus on single interventions throughout the perioperative care pathway, and the synergistic effect remains inadequately studied yet. As, individual classic components of ERATS pathways are under development, and innovative versions emerge, this review summarizes contemporary developments across the pre-, intra-, and postoperative phases of lung cancer surgery, focusing on prehabilitation, three-dimensional (3D) imaging, uniportal robot-assisted thoracoscopic surgery (uRATS), non-intubated video-assisted thoracoscopic surgery (NI-VATS), locoregional anesthesia techniques, and drainless surgery. Furthermore, we explore their potential synergistic role in optimizing recovery after lung cancer surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.